Ratte anti-Maus IgG2a (Heavy Chain) Antikörper
(3 Referenzen)Kurzübersicht für Ratte anti-Maus IgG2a (Heavy Chain) Antikörper (ABIN2474718)
Target
Klonalität
Applikation
Klon
Isotyp
-
-
Bindungsspezifität
- Heavy Chain
-
Reaktivität
- Maus
-
Wirt
- Ratte
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Purified IgG2a from BALB/c mice
-
-
Goat anti-Mouse IgG2a (Heavy Chain) antibody (HRP)
ELISA, IHC, WB Polyclonal IgG HRP
Rat anti-Mouse IgG2a antibodyELISA, FACS Monoclonal SB84a IgG1 unconjugated
Rat anti-Mouse IgG2a antibody (PE)ELISA, FACS Monoclonal SB84a IgG1 PE
Rat anti-Mouse IgG2a antibody (HRP)ELISA, IHC Monoclonal SB84a IgG1 HRP
Goat anti-Mouse IgG2a (Heavy Chain) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
Goat anti-Mouse IgG2a antibody (PE) - PreadsorbedELISA, FACS Polyclonal IgG PE
Goat anti-Mouse IgG2a antibody (APC) - PreadsorbedELISA, FACS Polyclonal IgG APC
Goat anti-Mouse IgG2a antibody (Alkaline Phosphatase (AP))ELISA, FLISA Polyclonal IgG Alkaline Phosphatase (AP)
Goat anti-Mouse IgG2a antibodyELISA, FLISA Polyclonal IgG unconjugated
Goat anti-Mouse IgG2a (Heavy Chain) antibody (Alkaline Phosphatase (AP))ELISA, IHC, WB Polyclonal IgG Alkaline Phosphatase (AP)
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
-
-
: "Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies." in: PLoS ONE, Vol. 5, Issue 4, pp. e10105, (2010) (PubMed).
: "Increased B cell proliferation and reduced Ig production in DREAM transgenic mice." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 185, Issue 12, pp. 7527-36, (2010) (PubMed).
: "Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein." in: Vaccine, Vol. 24, Issue 19, pp. 4102-10, (2006) (PubMed).
-
: "Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies." in: PLoS ONE, Vol. 5, Issue 4, pp. e10105, (2010) (PubMed).
-
-
